A mathematical analysis of the plasma disappearance curves of simultaneously injected thyroxine-131 I and albumin-125 I allows the development of simple formulas for estimating the pool size and transfer kinetics of rapidly exchangeable intracellular thyroxine in man. Evidence is presented that the early distribution kinetics of albumin-125 I can be used to represent the expansion of the thyroxine-131 I-plasma protein complex into the extracellular compartment. Calculations indicate that approximately 37% of total body extrathyroidal thyroxine is within such exchangeable tissue stores. The average cellular clearance of thyroxine is 42.7 ml per minute, a value far in excess of the metabolic clearance of this hormone. Results of external measurements over the hepatic area and studies involving hepatic biopsies indicate that the liver is an important but probably not the exclusive component of the intracellular compartment. The partition of thyroxine between cellular and extracellular compartments is determined by the balance of tissue and plasma protein binding factors. The fractional transfer constants are inversely related to the strength of binding of each compartment and directly proportional to the permeability characteristic of the hypothetical membrane separating compartments. Appropriate numerical values for these factors are assigned. An increased fractional entrance of thyroxine-131 I into the cellular compartment was noted in a patient with congenital decrease in the maximal binding capacity of thyroxine-binding globulin and in three patients after the infusion [ 
Summary. A mathematical analysis of the plasma disappearance curves of simultaneously injected thyroxine-131I and albumin-1251 allows the development of simple formulas for estimating the pool size and transfer kinetics of rapidly exchangeable intracellular thyroxine in man. Evidence is presented that the early distribution kinetics of albumin-125I can be used to represent the expansion of the thyroxine-13I-plasma protein complex into the extracellular compartment. Calculations indicate that approximately 37% of total body extrathyroidal thyroxine is within such exchangeable tissue stores. The average cellular clearance of thyroxine is 42.7 ml per minute, a value far in excess of the metabolic clearance of this hormone. Results of external measurements over the hepatic area and studies involving hepatic biopsies indicate that the liver is an important but probably not the exclusive component of the intracellular compartment. The partition of thyroxine between cellular and extracellular compartments is determined by the balance of tissue and plasma protein binding factors. The fractional transfer constants are inversely related to the strength of binding of each compartment and directly proportional to the permeability characteristic of the hypothetical membrane separating compartments. Appropriate numerical values for these factors are assigned. An increased fractional entrance of thyroxine-""1I into the cellular compartment was noted in a patient with congenital decrease in the maximal binding capacity of thyroxine-binding globulin and in three patients after the infusion of 5,5-diphenylhydantoin. Decreased intracellular space and impaired permeability characteristics were observed in five patients with hepatic disease. Studies of the rate of entrance of thyroxine-'81I and albumin-125I into the pleural effusion of a patient with congestive heart failure suggested that transcapillary passage of thyroxine independent of its binding protein is not a predominant factor in the total distribution kinetics of thyroxine-'31I. The thesis is advanced that the distribution of thyroxine, *Submitted for publication July 18, 1966 ; accepted
Introduction
Albert and Keating (1) first demonstrated that a variety of tissues in the rat rapidly accumulate radioactivity after the intravenous injection of thyroxine-_311. By external radioactive measurements in man, Myant and Pochin (2) showed that a significant fraction of administered thyroxine-131I is concentrated in the hepatic area. Hazelrig (3) , utilizing rat liver perfusion studies performed by Flock and co-workers, indicated that hepatic thyroxine is in rapid equilibrium with hormone in blood. The reversible transfer of thyroxine between liver and blood in the isolated rat liver preparation has recently been considered in detail by Gorman, Flock, Owen, and Paris (4). Pochin (5) and subsequently Cavalieri and Searle (6, 7) postulated a similar relationship in man on the basis of an analysis of the kinetics of thyroxine-131I accumulation by the liver and the simultaneous disappearance of radioactivity from plasma.
In the present communication, the distribution kinetics of thyroxine-131I are analyzed by comparing over a 4-hour period the plasma disappearance curves of simultaneously injected thyroxine-13lI and albumin-'25I. A model system is proposed that allows kinetic description of the exchange between thyroxine in the instantaneous volume of distribution of albumin-125I and thyroxine outside this volume. The compartment comprising thyroxine outside the instantaneous volume of albumin-125I distribution can be identified, as a first approximation, with the intracellular compartment of exchangeable hormone. The role of cellular and extracellular factors in determining the partition of thyroxine between these compartments is analyzed under a variety of physiological and pathological settings.
Methods
For the acute distribution studies 5 to 10 ,uc of thyroxine-mI (SA 30 to 40 mc per mg) was mixed with an approximately equal amount of albumin-w'I (SA 0.25 to 1 ,uc per mg) in a solution of 1% human serum albumin.' Both thyroxine-'I and albumin-'I were obtained commercially 2 and utilized without further purification. The solution containing the two tracer materials was injected into an antecubital vein through the rubber segment of an intravenous infusion set. During the following 4 hours, serial blood samples were obtained from the contralateral arm through an indwelling catheter. Approximately 6 ml of blood was obtained at each time and anticoagulated with heparin. Plasma samples were assayed for 'I and '5I in a Packard autogamma spectrometer as previously described (8 The distribution kinetics of thyroxine-binding prealbumin (TBPA) and albumin were compared after the simultaneous injection of 10 ,tc TBPA-'311 and 10 ,uc albumin-'"I. TBPA was isolated from whole serum as previously described (9) . After iodination with 131I by the method of Greenwood, Hunter, and Glover (10), the preparation was further purified by starch gel electrophoresis (11) .
To determine whether thyroxine-binding proteins are present in the soluble fraction of liver homogenates, we performed the following experiment on two occasions. Portions of diagnostic liver biopsies obtained at the time of laparotomy were weighed, homogenized in 10 vol of 0.1 M physiologic saline (assuming a tissue density of 1), and centrifuged at 100,000 X g in a Spinco preparative ultracentrifuge for 60 minutes. Serum samples were also obtained from the same patients at the time of surgery. Serum was diluted in saline to the same extent as the liver biopsies. Radioactive thyroxine (0.03 sAg per ml solution) was added to the diluted serum, to the supernatant of the liver homogenate, to a mixture of equal parts of diluted serum and supernatant liver homogenate, and to buffer alone. All preparations were then subjected to conventional paper electrophoresis (glycine acetate, pH 8.6), and the distribution of radioactivity was assessed in a paper strip scanner (12) .
To obtain a direct estimate of hepatic thyroxine uptake, we gave four patients scheduled to undergo abdominal laparotomy a combined dose of thyroxine-"31I and al-diagnostic biopsies obtained at the time of laparotomy were lightly blotted and weighed. The contribution of thyroxine-'I in residual blood in the tissue specimen to the observed 'I counting rate could be assessed from the counting rate of albumin-"uI in the tissue and the ratio of "I to "I counting rates in a peripheral plasma sample obtained at the time of the biopsy. Thus, the net tissue uptake of thyroxine-"~I could be calculated from the difference in total counting rate of 181I of the sample and the contribution from residual blood within the specimen.
Theoretical analysis of the acute distribution kinetics of thyroxine-`LI. As a first approximation, the plasma disappearance curves of thyroxine-"31I and albumin-l'I can be analyzed without reference to the effects of metabolic transformation of either substance for the first 4 hours after intravenous injection. If we assume single compartmental kinetics and a normal half-life for thyroxine and albumin, less than 2% of the administered thyroxine and less than 1% of the administered albumin will be catabolized in 4 hours.4 Thus, the volumes of distribution of thyroxine-'31I and of albumin-"2I at any time t during the first 4 hours after the injection of the tracers can be obtained from the reciprocal of their plasma concentrations.
In the Results section experimental data will be presented to substantiate the following assumptions: 1) The distribution kinetics of the thyroxine-'=I-plasma protein complex can be represented by those of albumin-'I. 2) Mixing of thyroxine in the extracellular compartment is largely governed by the mixing of the carrier protein.
3) The rapid escape of thyroxine-"1'I from the albumin distribution space after intravenous injection is due predominantly to the intracellular accumulation of tracer.
Nt, the per cent of administered thyroxine-'I outside the albumin distribution space at any time t during the first 4 hours after injection, will be the product of the instantaneous concentration of thyroxine-'I (Tt) expressed as per cent of the dose per liter and the differences in the volumes of distribution of thyroxine-'I and albumin-"I expressed in liters (VT -VA). Since VT = (100/Tt) and VA = (100/at), where at is the instantaneous concentration of albumin-'I, it follows that
Analysis of the acute distribution kinetics of thyroxine-19'I and albumin-'2I is complicated by the finding that the initial distribution volume of thyroxine is frequently larger than that of albumin as determined by extra4The urinary excretion of "~'I was measured in four patients after the intravenous injection of thyroxine-"sI. [3]
The per cent of thyroxine remaining in the extracellular compartment at time t, Et, will then be 100 -It. Alternative and probably equally justified interpretations of the initial discrepancy would lead to results substantially similar to those presented here since the volume difference under consideration is relatively small (less than 5%o).
Curves illustrating It as a function of time are presented in the Results. It can be seen that It achieves a plateau value between 3 and 4 hours after the administration of the isotopes. The shape of the intracellular accumulation curve suggests that it can be described by an exponential growth curve of the general form t= Imx(1 -ext).
[4]
The adequacy of this function in describing the function It can be graphically tested. If we rearrange the terms of Equation 4 , Imax -It = Imaxe-)t.
[5]
The linearity of (Imax -It) as a function of t on a semilogarithmic plot with an intercept of Im.x on the ordinate is also illustrated in the following section. In all subjects and patients that we have studied to date Equation 4 appears to describe the observed intracellular accumulation curve within the limits of experimental error. The function described by Equation 4 is known to represent the accumulation of isotope in one of the compartments of a closed two compartmental system as is illustrated in Figure 1 . The properties of a closed two compartmental model have previously been discussed by Solomon (14) . Isotope is injected into compartment 5 One possible source of the discrepancy between the extrapolated initial distribution volume of thyroxine-"sI and albumin-'lI is the presence of contaminating radioactive iodide and of radioactive thyronines (3,5,3'-triiodothyronine and 3,5',3'-triiodothyronine) in the thyroxine preparations used (13) . Such contaminants, being less tightly bound to plasma proteins than thyroxine, may also be responsible for a slight overestimation of the fractional rate of exit of thyroxine from the plasma compartment. The significance of these contaminants is further discussed in connection with the pleural effusion study. E at t = 0. The defining equations of the system are (dEt/dt) = -(kE)Et + (kl)lt, and (dlt/dt) = -(kI)lt + (kE)Et, [6] [ 7] where Et and It represent the per cent of the inj ected dose within compartments E and I at any time t, ks, is the fractional transfer constant from compartment E to compartment I, and k1 is the fractional transfer constant in the opposite direction.
Solution Thus, at t = a, It will reach a maximal value of Imox = lOOkE/(kE + ki), and Et will reach a minimal value at equilibrium of Emin = 100kI/(kE + ki). Moreover, X = ki + kE. [8] [9] [10] [11] [12] The volume of compartment E can be defined as VE = Emin/Teq, where Em.n and Teq represent the per cent of the dose in the extracellular compartment and the simultaneous plasma concentration of thyroxine-"'1I in the plasma when the two compartments come to equilibrium relative to each other. Analogously, the volume of compartment I can be defined as VI = Imax/Teq. Although the volume of the intracellular compartment is a useful concept, no immediate anatomical significance should be assigned to it.6 6 Actually, the volumes of compartments E and I (not to be confused with the volumes of distribution of thyroxine-J'I and albumin-'I) are expanding during the period of observation. Initially, the volume of compartment E is that of the plasma volume, about 3.2 L. At the equilibrium time, the volume of E is 4.2 L. A similar relative increase occurs in compartment I. Nevertheless, the interchange of thyroxine between these compartments can be treated as though we were dealing with two static compartments, the volumes of which were determined at equilibrium time. The reason for this lies in the fact that fractional exchange of thyroxine between the two compartments is relatively independent of the compartment size during the period of observation.
An alternative kinetic scheme would involve an unrestricted two compartmental model analogous to that originally employed by Berson and Yalow (15) and more recently by Cavalieri and Searle (7) . In such a system an interchange between the plasma compartment and compartment I would occur, but no restrictions would be placed on the movement of thyroxine out of the plasma compartment into the interstitial compartment. Solution of such a model would yield essentially similar results. The fractional transfer constants from the plasma compartment to the intracellular compartment kp would The nature of the equilibrium time deserves comment. This is the theoretical point at which the flux of thyroxine-J'I from the extracellular compartment to the intracellular compartment is equal to the flux in the opposite direction. On the time scale used in these studies, the point is determined as the midpoint of the Im.
plateau. At this point the specific activity of thyroxine in both compartments can be assumed to be equal. Since the concentration of unlabeled thyroxine can be determined from the chemical protein-bound iodine (PBI), the exchangeable pools of thyroxine in both compartments can be calculated from the data at hand. Thus, ZI= VI(r), [13] and ZE = VE(r), [14] P can be evaluated by equilibrium dialysis. In an equilibrium dialysis system in which serum is diluted by a factor of 150, P = 150/DF, where DF represents the dialyzable fraction (8) . The over-all binding by the extracellular compartment can be obtained by multiplying P and Vs, the volume of the extracellular compartment at the equilibrium time. Thus, if we substitute into Equation 15 and rearrange terms, h = (150/DF)(VE)(kE).
[16]
The value for kim can be determined as follows. The function X can be determined graphically from a plot of log (Imax-It) against t (Equation 5). From Equations 10 and 11, it follows that [17] where Z, and ZE are the pool sizes of thyroxine in compartments I and E, respectively, and r is the concentration of circulating thyroxine in plasma. It is apparent that if thyroxine-'I accumulation in the intracellular compartment were followed for a longer period and plotted on a time scale of days rather than hours, the apparent plateau level of It would be reduced to a maximal point with a subsequent downward deflection of the curve representing the net effects of thyroxine metabolism and the further distribution of thyroxine into the extracellular compartment. Data will be presented to indicate that the transfer of thyroxine from the extracellular compartment to the intracellular compartment is dependent in part on the strength of thyroxine binding by the plasma proteins.
The model system proposed can be used to quantitate this effect of protein binding. Thus, the fractional transfer constant kE can be expressed as kE = h/bE, [15] where h is a permeability factor (liters per minute) dependent on the properties of the hypothetical composite membrane separating compartments including its surface area and effective porosity7 and bE is a term (liters) representing over-all binding of thyroxine by plasma proteins in the extracellular compartment. The strength of thyroxine binding by plasma proteins can be represented n by the expression P _ L k,(Mi -TPI), where ki is the apparent association constant of the ith species of a total of n binding sites, M4 the molar concentration of the ith binding sites, and TP,, the molar concentration of the ith thyroxine binding site complex. This expression is, in essence, a measure of the effective concentration of unoccupied thyroxine binding sites in plasma. The value simply be related to kim by the following relationship: kE/kp = Va/VE, where Va is the plasma volume.
7This is not to suggest that the exchange between the extracellular and intracellular compartments is necessarily a passive phenomenon. The concept of effective porosity is used purely in an operational sense and can be represented by a number of physical models any of which could depend on active cellular metabolism. 
Results
Evidence supporting the use of albumin-125I in tracing the distribution of thyroxine-'111 into the extracellular space Distribution of the thyroxine-binding proteins. The plasma disappearance curves of simultaneously injected TBPA-'31I and albumin-125I for the first 4 hours are illustrated in Figure 2 . Similar results were observed in a second study. Plasma levels of the two iodinated proteins do not differ appreciably during the period of observation. The data indicate that the acute distribution kinetics of TBPA and albumin are similar and consonant with previous demonstrations that the space of TBPA distribution is the same as that of serum albumin (16, 17 were, therefore, applied to obtain information about the distribution of this protein. As will be shown subsequently, a large fraction of administered thyroxine-'31I leaving the plasma compartment enters the liver. If intrahepatic thyroxine exists as a thyroxine-TBG complex, one should be able to detect TBG in the soluble fraction of liver homogenates. Results of two separate experiments failed to disclose evidence of any strong soluble intracellular binding protein capable of competing effectively with plasma proteins for thyroxine. Thyroxine-181I added to the supernatant fraction migrated electrophoretically as a single peak with a mobility identical to that of thyroxine-131I alone. Moreover, when the supernatant fraction was mixed with an equivalent volume of appropriately diluted serum, the mobility and distribution of thyroxine-131I were identical to those of an equivalent dilution of serum in saline. These results suggest that TBG is not present in the soluble fraction of liver homogenates.
Evaluation of the possible influence of differential transcapillary migration of thyroxine and its binding proteins. Current estimates based on equilibrium dialysis of serum against aqueous buffer have suggested that from 0.030 to 0.050% of total circulating thyroxine is unbound (8, (18) (19) (20) . If this free fraction diffused very rapidly across the capillary endothelium, it would be theoretically possible for thyroxine to distribute itself in the extracellular space more rapidly than its binding proteins. The kinetic analysis proposed in this paper assumes that such independent diffusion is quantitatively unimportant. The ex-perimental findings underlying this assumption will be presented.
Since interstitial fluid in man is generally unavailable for sampling, the movement of simultaneously injected thyroxine-131I and albumin-125I from the plasma into the pleural effusion of a 65-year-old man was studied. The pleural fluid had an albumin concentration of 2.1 g and a globulin concentration of 1.7 g per 100 ml. The concomitant plasma albumin and globulin concentrations were 3.4 and 3.6 g per 100 ml, respectively. The PBI concentration of the effusion was 3.4 ,ug per 100 ml, and that of the plasma was 6.1 ug per 100 ml. It should be noted parenthetically that the ratio of PBI concentrations in pleural fluid and plasma, 0.56, approximates within experimental error the ratio of albumin concentrations, 0.62. Also, the distribution of tracer thyroxine-131I among binding proteins after paper electrophoresis was identical in both fluids. These findings suggest that the movement of thyroxinebinding proteins across this capillary bed is similar to that of serum albumin. 8 The concentration of thyroxine-131I and albumin-125I in plasma and pleural fluid is illustrated in Figure 3 . At the end of 4 hours, the specific activities of both tracers in the pleural fluid were less than one-tenth that of plasma. Because of the slow movement of both tracers the radioactivity in pleural fluid up to 40 minutes was found to be predominantly derived from contaminating iodide present in the original shipments of the tracers. Accordingly, all samples, both of pleural fluid and plasma were precipitated with TCA to remove the bulk of iodide. Nevertheless, the problem of coprecipitation of iodide with thyroxine (12) prevented accurate measurements until the 60-minute pleural sample.
An estimate of the relative fractional rate of entrance of thyroxine-131I and albumin-125I into the pleural fluid can be obtained from the follow8This suggestion, of course, is predicated on the assumption that the fractional removal rates of the various components in the pleural space (PBI, TBPA, TBG, and albumin) are similar. Moreover, the pleural fluid should not be considered necessarily representative of the extravascular fluid in general. In this connection, however, it is of interest to note that the ratio of the concentrations of PBI to protein in thoracic duct lymph is the same as that in serum (7) . a N. ing considerations. Assume that the movement of both tracers from the plasma compartment to the pleural compartment obeys first-order kinetics. Since the movement of both tracers is slow and the plasma-pleural system far from equilibrium, it can be assumed that the net movement of tracers out of the pleural fluid is negligible during the interval under consideration. Thus, (CT)t(Ve) = (kT, i)Va Ttdt, [24] where (cT) t is the concentration of thyroxine-131I in the pleural fluid at time t (per cent dose per liter); Ve, the volume of the pleural effusion (liters); kT,i, the fractional transfer constant from the plasma compartment into the pleural compartment (minutes-'); V., the plasma volume (liters); and Tt, the concentration of thyroxine-"'I in plasma at time t (per cent dose per liter). [26] where (ce) t is the concentration of albumin-'25I in the pleural fluid at any time t; ka,i, the fractional transfer constant of albumin-125I from the plasma compartment to the pleural compartment; and at the concentration of albumin-125I in the plasma at any time t. From Equations 20 and 21, it follows that 240 kT, i (CT)240 -(CT)60 J0 [27] ka, i L(Ca)240-(Ca)60 i240
Values for CT and ca are directly available, and the integral expressions can be evaluated graphically. The above ratio of the fractional transfer constants was determined to be 1.25. Thus, the possibility exists that there is a 25% faster ingress of thyroxine into the pleural fluid and that this difference could be due to independent diffusion of hormone. It appears likely, however, that the calculated ratio of 1.25 is an overestimation. Recent observations (13) have indicated that Abbott thyroxine-151I is contaminated with several per cent radioiodinated 3,5,3'-L-triiodothyronine and 3,5',3'-L-triiodothyronine. These substances are much less strongly bound to plasma proteins than thyroxine. Thus, material appearing in the pleural fluid in the early phase of the equilibrium period could contain a disproportionate contribution from these iodinated contaminants. Even if we assume that the ratio of the fractional transfer constants is correct, calculations based on this figure would suggest that the effects of independent transcapillary diffusion of thyroxine are negligible in terms of the over-all distribution kinetics of thyroxine. In this patient initial clearance of albumin-'25I from plasma, estimated from the graphically determined initial fractional exit rate and the plasma volume, is 6.24 ml per minute. Similarly, the total clearance of thyroxine from the plasma in this patient is 37.6 ml per minute. If independent thyroxine diffusion is 25 % of the albumin clearance, the clearance of thyroxine from plasma by means of independent diffusion is 1.56 ml per minute. Thus, independent diffusion would constitute only 4.1% [= (1.56/ 37.6) X 100] of the total thyroxine clearance. Since the 25%o figure is probably an overestimation, as pointed out above, the effects of independent diffusion are minimal.
This analysis is based on the assumption that permeability characteristics of the pleural capillary bed in the patient studied are typical of other capillary beds that allow only slow transcapillary passage of protein. The fact that tracer thyroxine is cleared initially at a sixfold greater rate than tracer albumin from the plasma compartment can readily be attributed to the more rapid rate of equilibration of protein across selected capillary beds such as the hepatic sinusoids (21) . A small pool of rapidly exchangeable protein in such beds would not greatly influence the apparent initial disappearance rate of albumin-'3,I from the plasma but would serve to facilitate a rapid and direct exchange of thyroxine from plasma protein to cellular receptor sites.
The transport of thyroxine from the interstitial space into the cells would thus not be limited by the diffusion of thyroxine in an aqueous medium or by the transcellular movement of plasma binding proteins. (Table I) The results of a representative study in a normal subject are illustrated in Figure 5 Figure 6 . Kinetic data on six nor-, mal subjects are summarized in Table I. WS. T I, = maximal fraction of administered dose thyroxine-1311 calculated to be within intracellular compartment. § Fatty infiltration, indicated by liver biopsy, may account for relatively low I.. and hepatic uptake.
Results of hepatic biopsies obtained approximately 4 hours after the injection are indicated in Table II . If we assume that the weight of the liver is 2%o of the body weight, the thyroxine-131I content of liver is on the average approximately 70% of the calculated Imax. The impor-DH. tant contribution of the liver to intracellular accumulation of thyroxine-131I is also indicated by results of studies in five patients with liver disease due to Laennec's cirrhosis or acute hepatitis (Table I ). Figure 7 illustrates the characteristic changes in the plasma disappearance curve of thyroxine-131I. The calculated intracellular accumulation of thyroxine (Imax) was markedly Figure 8 ).9 The concentration 9 Kindly referred to our attention by Dr. B. Segal. of thyroxine-131I falls precipitously after injection, leading to the calculated increase in kE and I.a..
The values for k, and the permeability factor h/VE are within the normal range. Although the calculated extracellular pool of thyroxine at the equilibrium time is reduced, the calculated intracellular pool is normal. Thus, the observed changes in the partition of tracer can be attributed exclusively to an alteration in the maximal binding capacity of TBG.
The role of binding proteins in regulating the partition of -thyroxine-131I between extracellular and cellular compartments is also apparent from the effects of the intravenous injection of diphenylhydantoin, a drug known to displace thyroxine from TBG and lower the serum PBI (22) (23) (24) . Studies were carried out in three patients. Diphenylhydantoin (150 mg) was infused when the intracellular accumulation curve had reached a plateau value. Results in a representative study are indicated in Figure 9 . Within minutes after the injection, there was a downward deflection of the plasma thyroxine-'31I curve. No change in the albumin-125I curve was noted. The calculated intracellular accumulation rose from 46 to 52%o of the administered dose. Discussion A number of assumptions underlying this analysis deserve special consideration. In interpreting the results of the plasma disappearance curves and in estimating thyroxine accumulated in the hepatic samples, we have tacitly assumed that serum albumin is predominantly extracellular.
Although intracellular albumin (or material immunologically related to albumin) has been demonstrated by immunofluorescence (25, 26) , this is not considered to be quantitatively significant in relation to the mass of extracellular protein (27) . Moreover, radioautographic studies carried out in the rat during the initial distribution period of albumin and thyroxine revealed no intracellular localization of albumin-125I but diffuse cytoplasmic distribution of thyroxine-'25I (28) .
This observation justifies, in part, the use of the term "intracellular," since selective concentration of thyroxine-125I in the interstitium or on the surface of cell membranes could not be demonstrated.
We have also assumed that the distribution of TBG does not differ significantly from that of albumin and TBPA. Direct proof of this assumption must await the purification of TBG so that the kinetics of labeled TBG can be measured. Nevertheless, our failure to find TBG in the soluble fraction of liver homogenate serves largely to exclude TBG as the transport vehicle across the hepatic cell membrane. If TBG were indeed responsible for the intracellular accumulation of thyroxine, one would expect to find at least two to three times the concentration of TBG in liver as in plasma, based on the relative concentrations of thyroxine in liver and plasma. Our data do not exclude the possibility that TBG may be strongly associated with particulate cellular elements, but in such an event it would be difficult to assign to intracellular TBG the transport function that would be required by a rapid two way exchange across the cell membrane. Moreover, other studies have failed to demonstrate greater thyroxine binding by particulate elements than by the cell sap of hepatic cells (29, 30) . Lastly, the argument previously advanced by Cavalieri and Searle (6) strongly militates against any possible role of TBG in transcellular transport. In patients with congenitally low TBG one would not expect increased hepatic uptake of administered tracer thyroxine if TBG were indeed responsible for transcellular thyroxine transport.
The importance of the liver in the extravascular distribution of thyroxine is illustrated by the diminished intracellular thyroxine in patients with liver disease, by the close correspondence of the rates of intracellular and hepatic uptake of thyroxine-31I, and by the liver biopsy data. Estimates based on the normal histological specimens listed in Table II (i.e., excluding ZF) suggest that approximately 78%o of the calculated intracellular thyroxine is intrahepatic. If we assume a normal intracellular volume of thyroxine distribution of 4.5 L, our estimate of intracellular hepatic thyroxine will be 3.5 L. This figure is in excellent agreement with the recent calculations of Cavalieri and Searle (7) for extravascular hepatic thyroxine space, 3.8 L ± 0.5 (SD). This correspondence serves to strengthen the underlying assumptions made in our analysis and to confirm our radioautographic data suggesting only negligible concentration of thyroxine in interstitial hepatic spaces.10
Since 78% of the calculated intracellular thyroxine space can be attributed to cellular hepatic uptake, the question arises as to the partition of the remaining 227o. Preliminary data obtained from experimental animals (rabbit, dog, rat) suggest that the kidney also makes a significant contribution to the net intracellular thyroxine compartment. In a patient with hepatic cirrhosis and a diminished thyroxine-'31I uptake by the liver, the renal outlines were clearly demonstrated by external radioactive scanning 4 hours after the administration of thyroxine-131I. In normal subjects, the kidneys are not seen under these circumstances, probably because of the interference from hepatic concentration of radioactivity. Insufficient data are available to make a quantitative estimate of renal thyroxine uptake in man or to assess the contribution of other tissues. The technical limitations in our study previously cited also do not allow us to rigorously exclude the possibility that a small proportion of the remaining 22%o of radioactivity is in fact associated with plasma proteins outside the instantaneous albumin-'25I distribution space.
The rapid exit of thyroxine from the albumin distribution volume clearly cannot be attributed to the effects of metabolic transformation of thyroxine. The average normal cellular clearance of thyroxine (VEkE) is 42.7 ml per minute. If we assume an average thyroxine distribution volume in these patients of 12.7 L based on a mean weight of 79.8 kg (31) and a thyroxine half-life of 6.0 days, the metabolic clearance can be estimated to be approximately 1.0 ml per minute. It follows that thyroxine must return from the intracellular compartment without having undergone effective metabolic transformation. This conclusion is in essential agreement with the findings of others (4, 5, 7) . 10Rapid equilibrium of albumin-'I between the vascular and interstitial spaces of the liver has been established (21) . Calculations based on the three normal hepatic biopsy specimens listed in Table II indicate that the average total thyroxine distribution volume per gram of wet tissue is 2.88 ml plasma. The average albumin distribution volume in the same specimens was 0.14 ml plasma. Thus 20.5 (=2.88/0.14) times as much thyroxine is associated with the cellular components as with plasma protein' in the vascular and extravascular spaces.
The fraction of administered thyroxine-131I within the intracellular compartment (Imax) was evaluated at a time between 3 and 4 hours after injection of the isotopes, when the intracellular and extracellular compartments were in equilibrium relative to each other. At this time, however, albumin-125I and presumably the thyroxine-131I-plasma protein complex are not yet completely distributed in the total extravascular protein space. Several days are required for complete distribution equilibrium of isotopic albumin. The proportion of total body thyroxine in the rapidly exchangeable tissue pools may thus be less than Ima,,. The partition of unlabeled thyroxine between cellular and extracellular thyroxine can be estimated from the following considerations. If we assume that the ratio of extravascular to intravascular albumin as determined by multicompartmental analysis is 1.33 (32) , the final average albumin-125I distribution volume in our series of normal subjects can be estimated to be 7.53 L. Thus, the average distribution volume of thyroxine in these subjects, estimated from the sum of the final albumin-125I distribution space and the intracellular distribution space of thyroxine, is 12.0 L. This is in excellent agreement with the predicted value of 12.7 L for the thyroxine distribution space calculated for an average weight of 79.8 kg from the empirical formula proposed by Oddie, Meade, and Fisher (31). Our findings would, therefore, suggest that 37.3% (= 4.47/12.00) of total body thyroxine is situated within rapidly exchangeable tissue stores. Thus, in the normal group, the average estimated total body pool of thyroxine is 885 ug, of which 329 pg is intracellular. Further data supporting the validity of our estimate of intracellular thyroxine were derived from two additional studies in which the total distribution volume of thyroxine, estimated by extrapolation to t = 0 (33),11 was compared to the value representing the sum of the total albumin distribution volume obtained by the equilibrium time method (35) and the intracellular thyroxine distribution volume. In one patient the "1The extrapolation method along with other single compartmental analyses currently used for approximating the thyroxine distribution volume may result in an overestimation of the space. As pointed out by Rall, Robbins, and Lewallen (34) , however, this overestimation probably does not exceed 10% of the true value. extrapolated thyroxine volume was 11.6 L, whereas the sum of the albumin and intracellular spaces was 11.2 L. In the other patient, the corresponding values were 8.8 and 9.2 L.
The results of our studies strongly support one of our underlying assumptions, namely, that the distribution of labeled thyroxine into the extracellular space is largely, if not completely, determined by the distribution kinetics of the carrier proteins. Diffusion of thyroxine independent of its carrier proteins does not appear to make a significant contribution to the kinetics of extravascular distribution. Thyroxine appears to leave the vascular tree in association with its carrier proteins through openings in the endothelial membrane. The mechanism of such transcapillary movement of protein has been extensively discussed by Mayerson, Wolfram, Shirley, and Wasserman (21) .
The transfer of thyroxine from the extracellular to the cellular compartment probably also occurs as the consequence of an interaction between plasma protein and membrane receptor sites. Thus, the concept of free thyroxine may not be necessary in describing the acute distribution kinetics of the hormone. Measurement of the dialysis fraction (or per cent free thyroxine) by equilibrium dialysis, however, provides an index inversely related to the over-all strength of plasma protein binding. The absolute concentration of free thyroxine, determined from the product of the dialyzable fraction and the total thyroxine concentration in plasma, would then be proportional to absolute rate of unidirectional transfer. Robbins and Rall (36) have postulated that the turnover rate of thyroxine is proportional to the concentration of free thyroxine in plasma. Since the metabolism of thyroxine is related to cellular function, it would be of interest to determine in future studies whether the turnover of thyroxine is in fact more closely related to the exchangeable intracellular pool. We should anticipate that primary changes in plasma protein binding would result in similarly directed and proportional shifts in free thyroxine. and the intracellular pool.
On the other hand, primary changes in cellular binding would produce oppositely directed changes in free thyroxine and the intracellular pool.
The nature of intracellular binding and the character of the reversible thyroxine transport across the cell surface have not been established.
It is known that subcellular fractions can bind thyroxine (29, 30) . To what extent such binding contributes to the influx of thyroxine in vivo and to what extent active metabolic processes are required for the bidirectional movement of the hormone must be determined in future studies.
Lennon, Engbring, and Engstrom (37) first reported the slowed disappearance of intravenously injected thyroxine-1311 in patients with liver disease. An increased fractional disappearance of thyroxine--31I in patients with hyperthyroidism was also noted by these authors. Similar observations have been made in our laboratory and can be attributed, in our opinion, to the diminished binding of thyroxine by plasma proteins in this disease.
The diminished hepatic thyroxine space and decreased hepatic clearance in patients with liver disease described in the earlier communication by Cavalieri and Searle (6) correspond well with the relative changes in intracellular distribution and clearance of thyroxine reported here. Similarly, the alterations in hepatic distribution kinetics in two subjects with congenitally low TBG values recently reported by the same authors (7) correspond with similar shifts noted in our patient. It is apparent that cellular function must be considered in conjunction with the concentration and the affinities of the thyroxine-binding plasma proteins in assessing the extrathyroidal factors that govern the concentrations of circulating thyroxine.
The methods described in this paper for estimating intracellular thyroxine and characterizing the distribution kinetics of this hormone are technically simple since they require only the measurement of serial plasma samples and the application of uncomplicated formulas. If the investigator wishes to confine his attention to the measurement of the function Imax,, the procedure can be even further simplied since the number of plasma samples required can be significantly reduced.
